FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 331:1675-1679 December 22, 1994 Number 25 Next

	Full Text Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background People who take analgesic drugs frequently may be at increased risk of end-stage renal disease (ESRD), but the extent of this risk remains unclear.

Methods We studied 716 patients treated for ESRD and 361 control subjects of similar age from Maryland, Virginia, West Virginia, and Washington, D.C. The study participants were interviewed by telephone about their past use of medications containing acetaminophen, aspirin, and other nonsteroidal antiinflammatory drugs (NSAIDs). For each analgesic drug, the average use (in pills per year) and the cumulative intake (in pills) were examined for any association with ESRD.

Results Heavier acetaminophen use was associated with an increased risk of ESRD in a dose-dependent fashion. When persons who took an average of 0 to 104 pills per year were used for reference, the odds ratio of ESRD was 1.4 (95 percent confidence interval, 0.8 to 2.4) for those who took 105 to 365 pills per year and 2.1 (95 percent confidence interval, 1.1 to 3.7) for those who took 366 or more pills per year, after adjustment for race, sex, age, and intake of other analgesic drugs. When persons who had taken fewer than 1000 pills containing acetaminophen in their lifetime were used for reference, the odds ratio was 2.0 (95 percent confidence interval, 1.3 to 3.2) for those who had taken 1000 to 4999 pills and 2.4 (95 percent confidence interval, 1.2 to 4.8) for those who had taken 5000 or more pills. Approximately 8 to 10 percent of the overall incidence of ESRD was attributable to acetaminophen use. A cumulative dose of 5000 or more pills containing NSAIDs was also associated with an increased odds of ESRD (odds ratio, 8.8), but the use of aspirin was not.

Conclusions People who often take acetaminophen or NSAIDs have an increased risk of ESRD, but not those who often take aspirin.

Source Information

From the Welch Center for Prevention, Epidemiology, and Clinical Research (T.V.P., P.K.W., M.J.K.) and the Departments of Epidemiology (T.V.P., P.K.W., M.J.K.), Health Policy and Management (M.J.K.), and Medicine (P.K.W., M.J.K.), Johns Hopkins University School of Hygiene and Public Health and School of Medicine, Baltimore; and the Institute of Social and Preventive Medicine, University of Geneva, Geneva, Switzerland (T.V.P.).

Address reprint requests to Dr. Perneger at the Institute of Social and Preventive Medicine, University of Geneva, Centre Medical Universitaire Case Postale, 1211 Geneva 4, Switzerland.

Full Text of this Article

Related Letters:

Kidney Failure and Analgesic Drugs
Faich G., Nelson E. B., Horowitz R. S., Wilson V. L., Dart R. C., Perneger T. V., Whelton P. K., Klag M. J.
Extract | Full Text  
N Engl J Med 1995; 332:1514-1516, Jun 1, 1995. Correspondence

This article has been cited by other articles:

• Hansen, D. L., Hansen, E. H., Holstein, B. E. (2008). Using Analgesics as Tools: Young Women's Treatment for Headache. Qual Health Res 18: 234-243 [Abstract]  
• Dallenbach, M.F., Bovier, P.A., Desmeules, J. (2007). Detecting drug interactions using personal digital assistants in an out-patient clinic. QJM 100: 691-697 [Abstract] [Full Text]  
• Hemmelgarn, B.R., Culleton, B.F., Ghali, W.A. (2007). Derivation and validation of a clinical index for prediction of rapid progression of kidney dysfunction. QJM 100: 87-92 [Abstract] [Full Text]  
• Perlman, A. I., Sabina, A., Williams, A.-L., Njike, V. Y., Katz, D. L. (2006). Massage Therapy for Osteoarthritis of the Knee: A Randomized Controlled Trial. Arch Intern Med 166: 2533-2538 [Abstract] [Full Text]  
• Henrich, W. L., Clark, R. L., Kelly, J. P., Buckalew, V. M., Fenves, A., Finn, W. F., Shapiro, J. I., Kimmel, P. L., Eggers, P., Agodoa, L. E., Porter, G. A., Shapiro, S., Toto, R., Anderson, T., Cupples, L. A., Kaufman, D. W. (2006). Non-Contrast-Enhanced Computerized Tomography and Analgesic-Related Kidney Disease: Report of the National Analgesic Nephropathy Study. J. Am. Soc. Nephrol. 17: 1472-1480 [Abstract] [Full Text]  
• Chan, A. T., Manson, J. E., Albert, C. M., Chae, C. U., Rexrode, K. M., Curhan, G. C., Rimm, E. B., Willett, W. C., Fuchs, C. S. (2006). Nonsteroidal Antiinflammatory Drugs, Acetaminophen, and the Risk of Cardiovascular Events. Circulation 113: 1578-1587 [Abstract] [Full Text]  
• Proctor, R., Kumar, N., Stein, A., Moles, D., Porter, S. (2005). Oral and Dental Aspects of Chronic Renal Failure. J. Dent. Res. 84: 199-208 [Abstract] [Full Text]  
• Dionne, R. A., Haynes, D., Brahim, J. S., Rowan, J. S., Guivarc'h, P.-H. (2004). Analgesic Effect of Sustained-Release Flurbiprofen Administered at the Site of Tissue Injury in the Oral Surgery Model. J Clin Pharmacol 44: 1418-1424 [Abstract] [Full Text]  
• Curhan, G. C., Knight, E. L., Rosner, B., Hankinson, S. E., Stampfer, M. J. (2004). Lifetime Nonnarcotic Analgesic Use and Decline in Renal Function in Women. Arch Intern Med 164: 1519-1524 [Abstract] [Full Text]  
• Dieppe, P., Bartlett, C., Davey, P., Doyal, L., Ebrahim, S. (2004). Balancing benefits and harms: the example of non-steroidal anti-inflammatory drugs. BMJ 329: 31-34 [Full Text]  
• Hu, Z., Wells, P. G. (2004). Human Interindividual Variation in Lymphocyte UDP-Glucuronosyltransferases as a Determinant of In Vitro Benzo[a]pyrene Covalent Binding and Cytotoxicity. Toxicol Sci 78: 32-40 [Abstract] [Full Text]  
• Lorz, C., Justo, P., Sanz, A., Subira, D., Egido, J., Ortiz, A. (2004). Paracetamol-Induced Renal Tubular Injury: A Role for ER Stress. J. Am. Soc. Nephrol. 15: 380-389 [Abstract] [Full Text]  
• Silva, F. G. (2004). Chemical-Induced Nephropathy: A Review of the Renal Tubulointerstitial Lesions in Humans. Toxicol Pathol 32: 71-84 [Abstract]  
• Mackinnon, B., Boulton-Jones, M., McLaughlin, K. (2003). Analgesic-associated nephropathy in the West of Scotland: a 12-year observational study. Nephrol Dial Transplant 18: 1800-1805 [Abstract] [Full Text]  
• Ahmed, M. H., Ashton, N., Balment, R. J. (2003). Renal Function in a Rat Model of Analgesic Nephropathy: Effect of Chloroquine. J. Pharmacol. Exp. Ther. 305: 123-130 [Abstract] [Full Text]  
• MEHLISCH, D. R. (2002). The efficacy of combination analgesic therapy in relieving dental pain. Journal of the American Dental Association 133: 861-871 [Abstract] [Full Text]  
• Fored, C. M., Ejerblad, E., Lindblad, P., Fryzek, J. P., Dickman, P. W., Signorello, L. B., Lipworth, L., Elinder, C.-G., Blot, W. J., McLaughlin, J. K., Zack, M. M., Nyren, O. (2001). Acetaminophen, Aspirin, and Chronic Renal Failure. NEJM 345: 1801-1808 [Abstract] [Full Text]  
• Rexrode, K. M., Buring, J. E., Glynn, R. J., Stampfer, M. J., Youngman, L. D., Gaziano, J. M. (2001). Analgesic Use and Renal Function in Men. JAMA 286: 315-321 [Abstract] [Full Text]  
• Long, L., Soeken, K., Ernst, E. (2001). Herbal medicines for the treatment of osteoarthritis: a systematic review. Rheumatology (Oxford) 40: 779-793 [Abstract] [Full Text]  
• Audoly, L. P., Ruan, X., Wagner, V. A., Goulet, J. L., Tilley, S. L., Koller, B. H., Coffman, T. M., Arendshorst, W. J. (2001). Role of EP2 and EP3 PGE2 receptors in control of murine renal hemodynamics. Am. J. Physiol. Heart Circ. Physiol. 280: H327-H333 [Abstract] [Full Text]  
• Roth, S. H., Fleischmann, R. M., Burch, F. X., Dietz, F., Bockow, B., Rapoport, R. J., Rutstein, J., Lacouture, P. G. (2000). Around-the-Clock, Controlled-Release Oxycodone Therapy for Osteoarthritis-Related Pain: Placebo-Controlled Trial and Long-term Evaluation. Arch Intern Med 160: 853-860 [Abstract] [Full Text]  
• Fox, J. M., Schwarz, A. (1999). Doubts about a particularly high nephrotoxicity of combination analgesics. Nephrol Dial Transplant 14: 2966-2968 [Full Text]  
• Giltay, E. J, van Schaardenburg, D., Gooren, L. J G, Kostense, P. J, Dijkmans, B. A C (1999). Decreased serum biochemical markers of muscle origin in patients with ankylosing spondylitis. Ann Rheum Dis 58: 541-545 [Abstract] [Full Text]  
• Colletti, A. E., Vogl, H. W., Rahe, T., Zambraski, E. J. (1999). Effects of acetaminophen and ibuprofen on renal function in anesthetized normal and sodium-depleted dogs. J. Appl. Physiol. 86: 592-597 [Abstract] [Full Text]  
• De Broe, M. E., Elseviers, M. M. (1998). Analgesic Nephropathy. NEJM 338: 446-452 [Full Text]  
• Trinkhaus, J., Nathan, J., Beane, L., Meltzer, B. (1997). Acetaminophen (Tylenol): Johnson & Johnson and Consumer Safety. J Law Med Ethics 25: 49-57  
• Wacholder, S. (1995). Design issues in case-control studies. Stat Methods Med Res 4: 293-309 [Abstract]  
• Laporte, J.-R., Vidal, X., Carne, X. (1995). Gastrointestinal bleeding is common. BMJ 311: 391d-391 [Full Text]  
• Faich, G., Nelson, E. B., Horowitz, R. S., Wilson, V. L., Dart, R. C., Perneger, T. V., Whelton, P. K., Klag, M. J. (1995). Kidney Failure and Analgesic Drugs. NEJM 332: 1514-1516 [Full Text]  
• (1995). Do Analgesics Cause Renal Failure?. Journal Watch Dermatology 1995: 15-15 [Full Text]  
• (1994). DO ANALGESICS CAUSE RENAL FAILURE?. JWatch General 1994: 1-1 [Full Text]  
• Ronco, P. M., Flahault, A. (1994). Drug-Induced End-Stage Renal Disease. NEJM 331: 1711-1712 [Full Text]